ADVERTISEMENT

CABG Beats PCI Regardless of SYNTAX Score

Author and Disclosure Information
CABG remains the standard treatment option for patients with triple-vessel disease.

For patients with SYNTAX scores of 23-32, the two treatment strategies led to similar adverse event rates in the two treatment groups.

Dr. Shiomi said he had no disclosures. Dr. Zeymer said that the Institute of MI Research in Germany, where he works, has received research grant support from multiple cardiac-device companies.